Drugs / PRO95780
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00851136 | May 2009 → Jun 2010 | colorectal cancer | Genentech, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00497497 | Oct 2007 → Sep 2010 | colorectal cancer | Genentech, Inc. | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT00517049 | Mar 2008 → Dec 2009 | non-Hodgkin lymphoma | Genentech, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00480831 | Jun 2007 → Aug 2010 | non-small cell lung carcinoma | Genentech, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00543712 | May 2007 → May 2008 | chondrosarcoma | Genentech, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO95780 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00480831 ↗ |
| Route | Intravenous | “Intravenous repeating dose” NCT00480831 ↗ |